{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-000642","form_type":"8-K","ticker":"GNLX","cik":"0001231457","company_name":"GENELUX Corp","filed_at":"2025-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.135098+00:00","generated_at":"2026-05-24T05:32:29.068850+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Genelux prices $10.5M underwritten offering of 3M shares at $3.50/share","bullets":["Gross proceeds of $10.5M from 3,000,000 shares at $3.50 per share; closing expected March 26, 2025.","Underwriter receives warrant to purchase 120,000 shares at $4.20 per share, exercisable after 180 days.","Proceeds for working capital and continued clinical development of Olvi-Vec.","Titan Partners Group acting as sole bookrunner; offering under effective shelf registration S-3.","Shares sold in registered direct offering; underwriting discounts and expenses not yet disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-000642","json":"https://secwatch.observer/filing/0001641172-25-000642.json","markdown":"https://secwatch.observer/filing/0001641172-25-000642.md","text":"https://secwatch.observer/filing/0001641172-25-000642.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225000642/0001641172-25-000642-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225000642/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T05:32:29.068850+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}